drugset
drugset / Trial / NCT05008354

Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam

NCT05008354 ↗

Phase 4 Completed 30 enrolled Nasim Tabrizi Mazandaran University of Medical Sciences · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a two-arm parallel group randomized double-blind placebo-controlled trial with the aim of Investigating pyridoxine effect on behavioral side effects of levetiracetam in adult patients with epilepsy.

Timeline

Start
2020-10-01
Primary completion
2021-09-01
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pyridoxine Unknown 40 mg —

Indications

epilepsy